Redeye: Imint - A Good Start to 2022
Redeye comments on Imint’s Q1 report, which showed tenacity, and revises the sales estimates slightly upward. Imint is in an investment phase, increasing its R&D capabilities while inking deals in new verticals outside of the core smartphone market, further supporting the durability of the case. We also discuss the Generation 4 platform’s flexibility and technical barriers to entry.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/